Clinical Trials Logo

Clinical Trial Summary

Hypoglycemia (low blood glucose) is a very common problem in newborns, and has been associated with poor neurodevelopment, cognition, and school performance. At-risk newborns (infants of diabetic mothers [IDM], large [LGA] and small [SGA] for gestational age infants, and late preterm [LPT] infants) undergo a hypoglycemia screening protocol that involves numerous intermittent needle sticks to test glucose levels on bedside glucometers; however, continuous glucose monitoring (CGM, currently not approved for clinical use in babies), via a small sensor placed in the thigh (only 1 needle stick), would likely decrease pain while providing continuous glucose levels. This study will evaluate the feasibility, safety, and precision of CGM in at-risk newborns, and determine if this method would decrease the amount of painful procedures and episodes of hypoglycemia missed by intermittent sampling. As part of regular medical care, participants will undergo intermittent blood glucose screening with heel sticks as per the current hospital standard of care protocol. Regular medical care involves checking the participant's blood glucose via heel stick every few hours using a bedside glucometer, with another heel stick to confirm low values in the laboratory. If the participant has low values, he/she may be treated with oral glucose gel, feedings of breast milk or formula, or intravenous (IV) fluids in the Neonatal Intensive Care Unit (NICU). This research study involves placing a CGM device in addition to undergoing the current blood glucose screening protocol and treatment. As soon as possible after birth, a continuous glucose monitoring device (Dexcom G7) will be placed on the participant's thigh by a research team member, and will blindly continuously record glucose levels that will be analyzed after discharge. Everyone who agrees to participate in this study will have placement of this experimental device. The investigational device will stay in place for the same amount of time that a participant is undergoing blood glucose monitoring as per the current standard of care protocol, for a maximum of 7 days. A participant may need to have his/her blood glucose checked after 7 days for regular medical care (and not for research), because his/her glucose concentrations are still low. Being in the research study will not affect a participant's medical care, and will not affect how long he/she needs blood glucose monitoring or treatment. A research team member will place and remove the CGM. Nurses will evaluate the site of the device for signs of irritation, infection, bleeding, and any other issues at least 3 times per day. After discharge from the hospital, data will be collected from the participant's medical record and participant's mother's medical record, including the participant's sex and birth weight, blood glucose values, details of feedings, treatments given for low glucose concentrations, and NICU admission data. Data that will be collected from the participant's mother's medical record includes age and race, prenatal data, medical history, and medication use. The participant's parents will be asked to fill out a short survey about their experience with this device when it is removed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04386005
Study type Interventional
Source Milton S. Hershey Medical Center
Contact Jeffrey R. Kaiser, MD, MA
Phone 717-531-8413
Email jkaiser2@pennstatehealth.psu.edu
Status Recruiting
Phase N/A
Start date August 9, 2021
Completion date July 2024

See also
  Status Clinical Trial Phase
Completed NCT02583776 - Continuous Glucose Monitoring and Preterm Infants Phase 4
Not yet recruiting NCT05977972 - Pattern of Metabolic Causes of Neonatal Hypoglycemia
Recruiting NCT04458649 - Continuous Glucose Monitoring in Infants
Recruiting NCT05127070 - Evaluating the NeoTree in Malawi and Zimbabwe
Completed NCT03032523 - Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM) N/A
Completed NCT03726697 - Effect of Tahneek on Hypoglycemia in Newborn Infants N/A
Terminated NCT04085978 - Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
Terminated NCT05647798 - Intrapartum Glycemic Control in GDMA2 N/A
Not yet recruiting NCT04811612 - Comparing Heel Stick Glucoses in Neonates N/A
Not yet recruiting NCT02648555 - A Lifestyle Intervention to Improve in Vitro Fertilization Results N/A
Recruiting NCT06373432 - Frequency of Glucose Monitoring in Labor N/A
Completed NCT04030312 - Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant N/A
Completed NCT03076775 - Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study N/A
Completed NCT05022433 - Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
Recruiting NCT00332449 - Early Breast Feeding and Glucose Levels in High Risk Newborns N/A
Not yet recruiting NCT04869709 - Late Preterm Corticosteroids and Neonatal Hypoglycemia Phase 4
Completed NCT02523222 - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia N/A
Recruiting NCT04875624 - Neurodevelopment of Hypoglycemic Neonates
Completed NCT02605369 - SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan N/A
Withdrawn NCT03738293 - Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids